Galactosidase: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In biochemistry, '''galactosidases''' are enzymes that are "a family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage."<ref>{{MeSH}}</ref> ==Classif...) |
imported>Meg Taylor (subpages) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[biochemistry]], '''galactosidases''' are [[enzyme]]s that are "a family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage."<ref>{{MeSH}}</ref> | In [[biochemistry]], '''galactosidases''' are [[enzyme]]s that are "a family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage."<ref>{{MeSH}}</ref> | ||
==Classification== | ==Classification== | ||
* [[alpha-galactosidase]]. Alpha-galactosidase A is the enzyme that is deficient in [[Fabry's Disease]]. Recombinant preparations of alpha-galactosidase A are agalsidase beta (Fabrazyme) and agalsidase alfa (Replagal). Beano® is an oral alpha-galactosidase.<ref name="pmid17179052">{{cite journal| author=Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M et al.| title=Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. | journal=Ann Intern Med | year= 2007 | volume= 146 | issue= 2 | pages= 77-86 | pmid=17179052 | * [[alpha-galactosidase]]. Alpha-galactosidase A is the enzyme that is deficient in [[Fabry's Disease]]. Recombinant preparations of alpha-galactosidase A are agalsidase beta (Fabrazyme) and agalsidase alfa (Replagal). Beano® is an oral alpha-galactosidase.<ref name="pmid17179052">{{cite journal| author=Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M et al.| title=Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. | journal=Ann Intern Med | year= 2007 | volume= 146 | issue= 2 | pages= 77-86 | pmid=17179052 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=17179052 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=17179052 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref> | ||
* [[beta-galactosidase]]. Beta-Galactosidase A1 enzyme deficiency may cause [[gangliosidosis]]. [[Lactase]] is a beta-galactosidase. | * [[beta-galactosidase]]. Beta-Galactosidase A1 enzyme deficiency may cause [[gangliosidosis]]. [[Lactase]] is a beta-galactosidase. | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 08:34, 30 September 2009
- The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.
In biochemistry, galactosidases are enzymes that are "a family of galactoside hydrolases that hydrolyze compounds with an O-galactosyl linkage."[1]
Classification
- alpha-galactosidase. Alpha-galactosidase A is the enzyme that is deficient in Fabry's Disease. Recombinant preparations of alpha-galactosidase A are agalsidase beta (Fabrazyme) and agalsidase alfa (Replagal). Beano® is an oral alpha-galactosidase.[2]
- beta-galactosidase. Beta-Galactosidase A1 enzyme deficiency may cause gangliosidosis. Lactase is a beta-galactosidase.
References
- ↑ Anonymous (2024), Galactosidase (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Banikazemi M, Bultas J, Waldek S, Wilcox WR, Whitley CB, McDonald M et al. (2007). "Agalsidase-beta therapy for advanced Fabry disease: a randomized trial.". Ann Intern Med 146 (2): 77-86. PMID 17179052.